Efficacy of Coronary Angioplasty on Long-Term Outcome in Elderly Chinese Patients with ST Elevated Myocardial Infarction

被引:2
|
作者
Shen, JieYan [1 ]
Du, YongPing [1 ]
Song, Wei [1 ]
Liu, JianPing [1 ]
Jin, ShuXuan [1 ]
Bu, Jun [1 ]
He, Ben [1 ]
机构
[1] Shanghai Jiao Tong Univ, RenJi Hosp, Coll Med, Dept Cardiol, Shanghai 200127, Peoples R China
关键词
ST elevated myocardial infarction; Coronary angioplasty; Elderly; Mortality; CONTROLLED-TRIALS; AGE; INTERVENTION; MORTALITY; SURVIVAL;
D O I
10.1007/s12013-010-9083-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The benefit and efficacy of interventional coronary therapies in elderly patients is still a controversial subject, especially in parts of the world where traditional and conservative medicine is still mainstream. In China, the benefit of intervention is still questionable, hence, this study investigated the prognostic significance of coronary angioplasty on outcomes of elderly patients presenting with ST-segment elevated myocardial infarction (STEMI). The study cohort comprised of 270 elderly (age a parts per thousand yen 75 years) patients who had confirmed STEMI. Some 116 patients underwent coronary angioplasty (called CA group) and their prognoses and survival over the short- and long-term periods (up to 80 months) were compared to 154 comparable patients who received a noninvasive, more conservative medical therapy (non-CA group). The subsequent Kaplan-Meier survival curves and statistical analyses were used to ascertain any difference between the groups. There was no significant differences between the two groups in terms of their clinical presentation, clinical risk, cardiac features, medications and medical procedures, except that the peak creatine kinase was significantly higher in the CA group. The success rate of interventional percutaneous coronary intervention observed in the CA group was 92.4% and during the hospitalization period, there were fewer deaths in the CA group (11 vs. 61 in the non-CA group). Furthermore, after 1-year and up to 7 years postsurgery, the CA group had a significant survival when compared to the non-CA cohort. Analysis of the longer-term data, using multivariate Cox regression analysis after 80 months indicated a hazard ratio of mortality for patients in CA group to be 0.283 (95% CI: 0.140-0.534, P < 0.001). Also, multivariate logistic regression analysis identified conservative treatment, chronic renal failure, cardiac arrhythmia, chronic lung disease and left ventricular ejection fraction, as predictors of higher long-term mortality in elderly patients with STEMI. In conclusion, this study clearly indicates that elderly Chinese patients with STEMI who undergo coronary angioplasty benefit and have a better survival rates in both the short- and long-term.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [1] Efficacy of Coronary Angioplasty on Long-Term Outcome in Elderly Chinese Patients with ST Elevated Myocardial Infarction
    JieYan Shen
    YongPing Du
    Wei Song
    JianPing Liu
    ShuXuan Jin
    Jun Bu
    Ben He
    Cell Biochemistry and Biophysics, 2010, 57 : 59 - 65
  • [2] LONG-TERM OUTCOME OF CORONARY ANGIOPLASTY IN ELDERLY PATIENTS WITH POSTINFARCTION ANGINA
    INIGUEZ, A
    MACAYA, C
    HERNANDEZ, R
    ALFONSO, F
    GOICOLEA, J
    RIBERA, JM
    ZARCO, P
    EUROPEAN HEART JOURNAL, 1994, 15 (04) : 489 - 494
  • [3] Effect of invasive strategy on long-term outcome in elderly Chinese patients with non-ST-elevation myocardial infarction
    Huang, Shao-Sung
    Chen, Ying-Hwa
    Chen, Jaw-Wen
    Lin, Shing-Jong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B117 - B117
  • [4] Impact of coronary collaterals on long term outcome in patients undergoing primary angioplasty for ST elevation myocardial infarction
    Biscione, C.
    Sergnese, O.
    Scarfo, I. S.
    Aluigi, S.
    Forleo, G. B.
    Ferraiuolo, F.
    Sergi, D.
    Romeo, F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 303 - 304
  • [5] CORONARY ANGIOPLASTY IN THE ELDERLY - SHORT AND LONG-TERM OUTCOME
    LARAMEE, LA
    RHODES, IN
    WILLIAMS, WL
    HIGGINSON, LAJ
    MORTON, BC
    BEANLANDS, DS
    MARQUIS, JF
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B53 - B53
  • [6] Long-term outcome in diabetic patients after acute myocardial infarction treated with percutaneous coronary angioplasty
    Honisz, G
    Krupa, H
    Zieliñska, T
    Kowalczyk, K
    Lenarczyk, R
    Kowalski, O
    Prokopczuk, J
    Kalarus, Z
    EUROPEAN HEART JOURNAL, 2004, 25 : 240 - 240
  • [7] LONG-TERM OUTCOME IN THE THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION TRIAL
    CALIFF, RM
    TOPOL, EJ
    KEREIAKES, DJ
    GEORGE, BS
    ABBOTTSMITH, CW
    CANDELLA, RJ
    ARONSON, L
    PITT, B
    LEE, KL
    CIRCULATION, 1987, 76 (04) : 260 - 260
  • [9] Electrocardiographic assessment of myocardial perfusion and long-term outcome in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G.
    Suryapranata, H.
    Ottervanger, J. P. O.
    de Boer, M. J.
    Dambrink, J. H. E.
    Gosselink, A. T. M.
    Hoorntje, J. C. A.
    van't Hof, A. W. J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 46 - 46
  • [10] Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction
    Akgul, Ozgur
    Baycan, Omer Faruk
    Bulut, Umit
    Somuncu, Mustafa Umut
    Pusuroglu, Hamdi
    Ozyilmaz, Sinem
    Gul, Mehmet
    Demir, Ali Riza
    Yilmaz, Emre
    Yazan, Serkan
    Kokturk, Ugur
    Cetin, Ilyas
    Uyarel, Huseyin
    CORONARY ARTERY DISEASE, 2015, 26 (07) : 592 - 597